The International Neuroblastoma Risk Group (INRG) classification system
Analysing 8,800 patients worldwide, the INRG task force built a pretreatment classification for neuroblastoma using stage, age, histology, MYCN, chromosome 11q and ploidy that sorts children into very low, low, intermediate and high-risk groups.
Overview
Analysis of 8,800 children with neuroblastoma diagnosed between 1990 and 2002 from international cooperative groups, defining sixteen pretreatment groups by INRG stage, age, histological category, grade of differentiation, MYCN status, 11q aberration and ploidy, assigned to four risk groups by five-year event-free survival.
- Sixteen pretreatment groups collapsed into very low (over 85 percent event-free survival), low, intermediate and high risk (under 50 percent).
Every neuroblastoma risk group on this site (very low, low, intermediate, high) is defined by the INRG system, which allows trials across continents to be compared.
- Based on patients treated in the 1990s; contemporary outcomes are better in most groups.
- Segmental chromosome aberrations beyond 11q are being incorporated in revisions.
Similar pages
not linked directly; found by shared links- Key paperCOG P9641: surgery alone or with restricted chemotherapy for low-risk neuroblastoma
Shares Low-risk neuroblastoma (INRG very low and low risk, including stage MS), Journal of Clinical Oncology.
- Key paperANBL0531: response- and biology-based therapy for intermediate-risk neuroblastoma
Shares Intermediate-risk neuroblastoma, Journal of Clinical Oncology.
- Idea18F-MFBG PET replacing 123I-MIBG scintigraphy
Shares Low-risk neuroblastoma (INRG very low and low risk, including stage MS), Intermediate-risk neuroblastoma, High-risk neuroblastoma.
- TermINRG staging and risk groups
Shares Low-risk neuroblastoma (INRG very low and low risk, including stage MS), Intermediate-risk neuroblastoma, High-risk neuroblastoma.
- TermUrinary catecholamine metabolites (VMA and HVA)
Shares Low-risk neuroblastoma (INRG very low and low risk, including stage MS), Intermediate-risk neuroblastoma, High-risk neuroblastoma.
- TermSegmental chromosomal aberrations and ploidy (neuroblastoma)
Shares Low-risk neuroblastoma (INRG very low and low risk, including stage MS), Intermediate-risk neuroblastoma, High-risk neuroblastoma.
- TermMYCN amplification
Shares Low-risk neuroblastoma (INRG very low and low risk, including stage MS), Intermediate-risk neuroblastoma, High-risk neuroblastoma.
- TechnologyOncofertility and fertility preservation
Shares Intermediate-risk neuroblastoma, High-risk neuroblastoma.